Related Experiment Video
Updated: Jul 22, 2026
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Do physiological changes in pregnancy change defibrillation energy requirements?
J Nanson1, D Elcock, M Williams
1Shackleton Department of Anaesthesia, Southampton University Hospital NHS Trust, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK.
British Journal of Anaesthesia
|August 9, 2001
Summary
Transthoracic impedance (TTI) in pregnant individuals remains consistent from term pregnancy through postpartum recovery. This finding supports the continued use of standard adult defibrillation energy levels during pregnancy resuscitation efforts.
Area of Science:
- Cardiology and Critical Care Medicine
- Obstetrics and Gynecology
Background:
- Resuscitation during pregnancy is rare but critical, with potential physiological changes impacting transthoracic impedance (TTI).
- Pregnancy-induced physiological alterations like increased blood volume and thoracic changes may unpredictably affect TTI, influencing defibrillation efficacy.
Purpose of the Study:
- To measure transthoracic impedance (TTI) in pregnant individuals at term and postpartum.
- To determine if physiological changes during pregnancy significantly alter TTI.
- To assess the appropriateness of current adult defibrillation energy requirements for use during pregnancy.
Main Methods:
- Transthoracic impedance (TTI) was measured in pregnant individuals at term.
- TTI measurements were repeated 6-8 weeks after delivery, once physiological changes had resolved.
- Statistical analysis compared TTI values between the two measurement periods.
Main Results:
- Mean (SD) TTI at term was 91.3 (15.8) Ohms.
- Mean (SD) TTI 6-8 weeks postpartum was 91.6 (11.8) Ohms.
- The difference in TTI between term pregnancy and postpartum was not statistically significant.
Conclusions:
- Transthoracic impedance (TTI) does not significantly change due to pregnancy.
- Current energy requirements for adult defibrillation are deemed appropriate for use in pregnant patients.
- This supports the safety and efficacy of standard defibrillation protocols in obstetric emergencies.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...